1. Home
  2. FNWD vs NERV Comparison

FNWD vs NERV Comparison

Compare FNWD & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

N/A

Current Price

$41.52

Market Cap

187.1M

Sector

Finance

ML Signal

N/A

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

SELL

Current Price

$2.53

Market Cap

166.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FNWD
NERV
Founded
1994
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.1M
166.4M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
FNWD
NERV
Price
$41.52
$2.53
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
7.9K
★ 137.0K
Earning Date
10-29-2026
11-04-2026
Dividend Yield
★ 1.15%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.00
N/A
Revenue
N/A
★ $41,175,600.00
Revenue This Year
$10.81
N/A
Revenue Next Year
$5.26
N/A
P/E Ratio
$41.75
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.05
$2.39
52 Week High
$45.90
$12.46

Technical Indicators

Market Signals
Indicator
FNWD
NERV
Relative Strength Index (RSI) 42.61 22.36
Support Level $34.83 N/A
Resistance Level $44.01 $4.73
Average True Range (ATR) 0.61 0.25
MACD -0.06 -0.04
Stochastic Oscillator 16.57 2.26

Price Performance

Historical Comparison
FNWD
NERV

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: